Pharmafile Logo
Pharmafocus logo
Advanced Search

immunocore

Showing 9 posts of 9 posts found.

astrazeneca_plaque

AstraZeneca loses two senior executives as biotechs appoint new CEOs

January 7, 2019
Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

News
Lilly image

Lilly and Immunocore collaborate on melanoma

June 29, 2015
Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly

Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …

News
MedImmune image

AstraZeneca signs immuno-oncology deal with UK firm

April 16, 2015
Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab

UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …

News
john_bell

Immunocore appoints key scientist to board

March 31, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell

UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …

Appointment
eliot_forster_immunocore_portrait_2

Immunocore names chief executive

January 14, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore

Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …

Appointment
Lilly image

Lilly signs Immunocore deal

July 17, 2014
Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

News
screen_shot_2014-03-27_at_07

Immunocore chief executive cements role at Adaptimmune

March 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble

Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …

Appointment
screen_shot_2013-11-19_at_08

Immunocore promotes non-executive to chairman

November 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles

Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …

Appointment
GSK image

GSK teams up with Oxford biotech on cancer

July 9, 2013
Research and Development, Sales and Marketing GSK, Oxford, immunocore

GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023